References
- Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-7. https://doi.org/10.1056/NEJM198608073150601
- Lee DB. Epidemiologic study of Kawasaki disease in Korea (1976-1984). J Cath Coll 1985;38:8-19.
- Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978;61:100-7.
- Melish ME. Kawasaki syndrome. Pediatr Rev 1996;17:153-62. https://doi.org/10.1542/pir.17-5-153
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178-222.
- Taubert KA. Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997;6:181-5. https://doi.org/10.1016/S1058-9813(97)00188-4
- Yanagawa H, Kawasaki T, Shigematsu I. Nationwide survey on Kawasaki disease in Japan. Pediatrics 1987;80:58-62.
- Kim GB, Han JW, Park YW, et al. Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 2014;33:24-7. https://doi.org/10.1097/INF.0000000000000010
- Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura N. High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr 1987;110:710-2. https://doi.org/10.1016/S0022-3476(87)80007-0
- Ahn SY, Hong SY, Kim NS, Lee HB, Moon SJ, Lee H. Comparison between treatment with aspirin alone and the combined treatment with aspirin and intravenous gamma-globulin in Kawasaki disease. J Korean Pediatr Soc 1990;33:1380-7.
- Kuribayashi S, Ootaki M, Tsuji M, Matsuyama S, Iwasaki H, Oota T. Coronary angiographic abnormalities in mucocutaneous lymph node syndrome: acute finding and long-term follow-up. Radiology 1989;172:629-33. https://doi.org/10.1148/radiology.172.3.2772168
- Nakashima L, Edwards DL. Treatment of Kawasaki disease. Clin Pharm 1990;9:755-62.
- Shim SY, Heo MY, Kim HS, Sonh SJ. High-dose intravenous immune globulin retreatment in Kawasaki disease. J Korean Pediatr Soc 2002;45:1273-7.
- Witt MT, Minich LL, Bohnsack JF, Young PC. Kawasaki disease: more patients are being diagnosed who do not meet American Heart Association criteria. Pediatrics 1999;104:e10. https://doi.org/10.1542/peds.104.1.e10
- Fukushige J, Takahashi N, Ueda Y, Ueda K. Incidence and clinical features of incomplete Kawasaki disease. Acta Paediatr 1994;83:1057-60. https://doi.org/10.1111/j.1651-2227.1994.tb12985.x
- Kato H, Ichinose E, Yoshioka F, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term followup study. Am J Cardiol 1982;49:1758-66. https://doi.org/10.1016/0002-9149(82)90256-9
- Mori M, Miyamae T, Imagawa T, Katakura S, Kimura K, Yokota S. Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease. Mod Rheumatol 2004;14:361-6. https://doi.org/10.3109/s10165-004-0324-3
- Park MJ, Jeon IS, Tchah H, Cho KH, Jung MJ, Choi DY. Predictive indicators of coronary artery complications in Kawasaki disease. Korean J Pediatr 2009;52:1161-6. https://doi.org/10.3345/kjp.2009.52.10.1161
- Cho KH, Kang SJ. Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete Kawasaki disease. Korean Circ J 2014;44:328-35. https://doi.org/10.4070/kcj.2014.44.5.328
- Stiehm ER. Lessons from Kawasaki disease: all brands of IVIG are not equal. J Pediatr 2006;148:6-8.